ASH: Incyte’s Monjuvi triumphs in follicular lymphoma phase 3, teeing up FDA filing
November 25, 2024Shorla gains FDA nod for first oral liquid version of Novartis’ Gleevec
November 26, 2024Fast-growing Adragos snaps up Swiss CDMO Baccinex, significantly expanding fill-finish firepower
fkansteiner
Tue, 11/26/2024 – 08:58
